Nanoparticles have many advantages for delivering drugs to the brain. More and more research suggested that these advantages are not simply summed up in the small size of nanoparticles. Studies have shown that lipid nanoparticles, polymer nanoparticles, silica nanoparticles, magnetic nanoparticles, and other nanoparticles are highly suitable for brain delivery, which depends on properties such as size, surface charge, the morphology of the nanoparticle, especially molecular recognition and interaction between specific ligands bound on the nanoparticle surface and molecules overexpressed on the brain target (active targeting). Ace Therapeutics offers a range of services to develop nanoparticle drug delivery systems for stroke treatment.
Selecting and identifying suitable nanomaterials is very important for constructing a nanomaterial delivery system. Therefore, Ace Therapeutics provides different ways to identify nanoparticles.
Given the multiple advantages of nanoparticles for brain targeted drug delivery, Ace Therapeutics provides comprehensive services to facilitate the development of nanoparticle drug delivery systems for stroke treatment, including nanoparticle design, nanoparticle distribution detection, drug encapsulation, and in vitro and in vivo metabolic studies.
Ace Therapeutics provides comprehensive services to measure the ability of nanomedicines to cross the BBB while performing pharmacokinetic testing of nanomedicines.
If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.